Enhanced lipid oxidation by oxidatively modified myoglobin: Role of protein-bound heme

Biochemical and Biophysical Research Communications

Volumn 269, Issue 3, 2000, Pages 647-651

  Vuletich, Jennifer L ^b   Osawa, Yoichi ^b   Aviram, Michael ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Enzyme catalysis; Free radicals; Heme; Hemoprotein; Lipid peroxidation; Low density lipoprotein; Metabolism; Myoglobin; Oxygen

Indexed keywords

ALKADIENE; APOPROTEIN; FREE RADICAL; HEME; HYDROGEN PEROXIDE; LIPID PEROXIDE; MYOGLOBIN; PHOSPHATIDYLCHOLINE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; CROSS LINKING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIPID PEROXIDATION; PRIORITY JOURNAL; PROTEIN BINDING;

EID: 0034708352     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2000.2349     Document Type: Article

References (27)

1. Steinberg D., Parthasarathy S., Carew T. E., Khoo J. C., Witztum J. L. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 320:1989;915-924.
2. Berliner J. A., Navab M., Fogelman A. M., Frank J. S., Demer L. L., Edwards P. A., Watson A. D., Lusis A. J. Atherosclerosis: Basic mechanisms. Oxidation, inflammation, and genetics. Circulation. 91:1995;2488-2496.
3. Aviram M. Interaction of oxidized low density lipoprotein with macrophages in atherosclerosis, and the antiatherogenicity of antioxidants. Eur. J. Clin. Chem. Clin. Biochem. 34:1996;599-608.
4. Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. J. Biol. Chem. 272:1997;20963-20966.
5. Aviram M. LDL-platelet interaction under oxidative stress induces macrophage foam cell formation. Thromb. Haemost. 74:1995;560-564.
6. Aviram M., Fuhrman B. LDL oxidation by arterial wall macrophages depends on the oxidative status in the lipoprotein and in the cells: Role of prooxidants vs. antioxidants. Mol. Cell. Biochem. 188:1998;149-159.
7. Miller Y. I., Altamentova S. M., Shaklai N. Oxidation of low-density lipoprotein by hemoglobin stems from a heme-initiated globin radical: Antioxidant role of haptoglobin. Biochemistry. 36:1997;12189-12198.
8. Dee G., Rice-Evans C., Obeyesekera S., Meraji S., Jacobs M., Bruckdorfer K. R. The modulation of ferryl myoglobin formation and its oxidative effects on low density lipoproteins by nitric oxide. FEBS Lett. 294:1991;38-42.
9. Miller Y. I., Smith A., Morgan W. T., Shaklai N. Role of hemopexin in protection of low-density lipoprotein against hemoglobin-induced oxidation. Biochemistry. 35:1996;13112-13117.
10. Paganga G., Rice-Evans C., Rule R., Leake D. The interaction between ruptured erythrocytes and low-density lipoproteins. FEBS. Lett. 303:1992;154-158.
11. Hogg N., Rice-Evans C., Darley-Usmar V., Wilson M. T., Paganga G., Bourne L. The role of lipid hydroperoxides in the myoglobin-dependent oxidation of LDL. Arch. Biochem. Biophys. 314:1994;39-44.
12. Kanner J., Harel S. Initiation of membranal lipid peroxidation by activated metmyoglobin and methemoglobin. Arch. Biochem. Biophys. 237:1985;314-321.
13. Catalano C. E., Choe Y. S., Ortiz de Montellano P. R. Reactions of the protein radical in peroxide-treated myoglobin: Formation of a heme-protein cross-link. J. Biol. Chem. 264:1989;10534-10541.
14. 2: Toxicological implications. Free Radical Biol. Med. 21:1996;35-41.
15. Osawa Y., Darbyshire J. F., Meyer C. A., Alayash A. I. Differential susceptibilities of the prosthetic heme of hemoglobin-based red cell substitutes. Biochem. Pharmacol. 12:1993;2299-2305.
16. Osawa Y., Pohl L. R. Covalent bonding of the prosthetic heme to protein: A potential mechanism for the suicide inactivation or activation of hemoproteins. Chem. Res. Toxicol. 2:1989;131-141.
17. Osawa Y., Korzekwa K. Oxidative modification by low levels of HOOH can transform myoglobin into an oxidase. Proc. Natl. Acad. Sci. USA. 88:1991;7081-7085.
18. 3: Covalent bonding of the proximal histidine to the ring I vinyl group. J. Biol. Chem. 266:1991;3208-3214.
19. Aviram M. Plasma lipoprotein separation by discontinuous density gradient ultracentrifugation in hyperlipoproteinemic patients. Biochem. Med. 30:1983;111-118.
20. Buege J. A., Aust S. D. Microsomal lipid peroxidation. Methods Enzymol. 52:1978;302-310.
21. El-Saadani M., Esterbauer H., el-Sayed M., Goher M., Nassar A. Y., Jurgens G. A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent. J. Lipid Res. 30:1989;627-630.
22. Esterbauer H., Striegl G., Puhl H., Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic. Res. Commun. 6:1989;67-75.
23. Sugiyama K., Highet R. J., Woods A., Cotter R. J., Osawa Y. Hydrogen peroxide-mediated alteration of the heme prosthetic group of metmyoglobin to an iron chlorin product: Evidence for a novel oxidative pathway. Proc. Natl. Acad. Sci. USA. 94:1997;796-801.
24. Vuletich J. L., Osawa Y. Chemiluminescence assay for oxidatively modified myoglobin. Anal. Biochem. 265:1998;375-380.
25. Osawa Y., Fellows C., Highet R. J. Buncel E., Kabalka G. W. Synthesis and application of isotopically labelled compounds 1991, proceedings of the fourth international symposium, Toronto, Canada. 1992;415-420 Elsevier Science, Amsterdam.
26. Moore K. P., Holt S. G., Patel R. P., Svistunenko D. A., Zackert W., Goodier D., Reeder B. J., Clozel M., Anand R., Cooper C. E., Morrow J. D., Wilson M. T., Darley-Usmar V., Roberts L. J. 2nd. A causative role for redox cycling of myoglobin and its inhibition by alkalinization in the pathogenesis and treatment of rhabdomyolysis-induced renal failure. J. Biol. Chem. 273:1998;31731-31737.
27. Aviram M., Kent U. M., Hollenberg P. F. Microsomal cytochromes P450 catalyze the oxidation of low density lipoprotein. Atherosclerosis. 143:1999;253-260.